glutathione and cancer riskbmj Application of depletion in therapy: Enhanced ROS-based therapy, ferroptosis, chemotherapy Antioxidants in cancer therapy mitigating
Description
There was no significant alteration in the activity of CAT from day 1 to day 30
In contrast, the daratumumab binding site is located completely outside the CD38 catalytic site [11]
Exp Mol Med 47:e131 Saha A, Robertson ES (2011) EpsteinBarr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes
Discussion GSH is a major antioxidant and a cofactor of many enzymes in the human body (1618)
